TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5/15/23 18:53 | 5/11/23 | NBY | Novabay Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Wu Mijia | CA | D | M.d | 0 | 0.00 | 0 | 1 | 100 | 2 | D | |||||||||||||||
5/24/22 19:33 | 5/21/22 | NBY | Novabay Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Wu Mijia | CA | D | M.d | 0 | 0.00 | 0 | 30 | New | 30 | D | |||||||||||||||
8/19/20 16:24 | 8/17/20 | NBY | Novabay Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Wu Mijia | CA | D | S.d | -27 | 1.35 | 0 | -20 | -100 | 0 | D | |||||||||||||||
6/13/19 06:03 | 6/10/19 | NBY | Novabay Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Wu Mijia | D | S.m | -161 | 2.53 | 0 | -63 | -100 | 0 | M |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |